C15H10Cl2N2O
305.2 g/mol
Pharmaceutical IntermediateWarning
Cmpcqo
CAS5958-24-7EC620-225-3
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a quinazoline derivative with a 3-oxide functional group, used as a pharmaceutical intermediate in research and manufacturing processes.
pharmaceutical intermediateresearch compound for impurity studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 5958-24-7
Related Compounds
ReferenceSame Category
4-amino-1-naphthol hydrochloride
CAS5959-56-8
pharmaceutical intermediate
ReferenceSame Category
4-methoxy-N-methylaniline
CAS5961-59-1
pharmaceutical intermediate
ReferenceSame Category
(3-Aminophenyl)-urea monohydrochloride
CAS59690-88-9
pharmaceutical intermediate
ReferenceSame Category
4-Ethyl-2,3-dioxo-1-piperazine carbonyl chloride
CAS59703-00-3
pharmaceutical intermediate
Referencesame scaffold
6-chloro-2-(chloromethyl)-4-(2-fluorophenyl)-3-oxideQuinazoline
CAS60656-74-8
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
6-chloro-2-(chloromethyl)-3-oxido-4-phenylquinazolin-3-ium
InChIKey
KFDNKXWSTFABQT-UHFFFAOYSA-N
SMILES
C1=CC=C(C=C1)C2=[N+](C(=NC3=C2C=C(C=C3)Cl)CCl)[O-]
Synonyms (14)
- Chlordiazepoxide EP Impurity B
- Chlordiazepoxide Hydrochloride Imp. B (EP); Chlordiazepoxide Imp. B (EP); 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-Oxide; Chlordiazepoxide Hydrochloride Impurity B; Chlordiazepoxide Impurity B; Chlordiazepoxide Impurity B
- Clonazepine EP impurity B
- CHLORDIAZEPOXIDE IMPURITY B
- Cmpcqo